Bank Of America Corp Harrow Health, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Harrow Health, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 26,599 shares of HROW stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,599

Previous 13,314 99.78%

Holding current value

$1.21 Million

Previous $176,000 215.34%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.0 - $21.64 $132,850 - $287,487	13,285 Added 99.78%	26,599 $555,000
Q1 2024 May 15, 2024	SELL	$9.3 - $13.23 $169,501 - $241,129	-18,226 Reduced 57.79%	13,314 $176,000
Q4 2023 Feb 14, 2024	BUY	$8.1 - $16.36 $161,538 - $326,267	19,943 Added 171.97%	31,540 $353,000
Q2 2023 Aug 14, 2023	SELL	$17.37 - $28.08 $401,559 - $649,153	-23,118 Reduced 66.59%	11,597 $220,000
Q1 2023 May 12, 2023	BUY	$13.84 - $21.46 $339,024 - $525,684	24,496 Added 239.71%	34,715 $734,000
Q4 2022 Feb 10, 2023	BUY	$10.28 - $14.78 $97,721 - $140,498	9,506 Added 1333.24%	10,219 $150,000
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $27,955 - $105,864	-4,255 Reduced 85.65%	713 $9,000
Q2 2022 Aug 12, 2022	BUY	$5.75 - $7.74 $5 - $7	1 Added 0.02%	4,968 $36,000
Q1 2022 May 16, 2022	BUY	$6.77 - $8.66 $3,412 - $4,364	504 Added 11.29%	4,967 $34,000
Q4 2021 Feb 08, 2022	BUY	$8.5 - $12.0 $31,237 - $44,100	3,675 Added 466.37%	4,463 $39,000
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $16,706 - $25,334	-2,390 Reduced 75.2%	788 $7,000
Q2 2021 Sep 13, 2021	BUY	$6.68 - $11.07 $21,229 - $35,180	3,178 New	3,178 $30,000

Others Institutions Holding HROW

# of Institutions

121

Shares Held

19.7M

Call Options Held

700K

Put Options Held

575K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.23B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Harrow Health, Inc. Transaction History